These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21849528)

  • 1. Treatment of pediatric Graves' disease is associated with excessive weight gain.
    van Veenendaal NR; Rivkees SA
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3257-63. PubMed ID: 21849528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Graves' disease: controversies in management.
    Rivkees SA
    Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of body weight in patients with Graves' disease during the treatment with methimazole].
    Moretto RL; Pedro AB; Leite AC; Romaldini JH
    Arq Bras Endocrinol Metabol; 2012 Aug; 56(6):364-9. PubMed ID: 22990640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain in patients after therapy for hyperthyroidism.
    Brunova J; Bruna J; Joubert G; Koning M
    S Afr Med J; 2003 Jul; 93(7):529-31. PubMed ID: 12939927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 9. Weight gain after treatment of Graves' disease in children.
    Alonso GT; Rabon S; White PC
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):66-70. PubMed ID: 29023978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
    Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
    Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
    Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
    J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
    Cooper DS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C; Xie J; Wang H; Li J; Chen S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?
    Tigas S; Idiculla J; Beckett G; Toft A
    Thyroid; 2000 Dec; 10(12):1107-11. PubMed ID: 11201857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.
    Sato H; Minagawa M; Sasaki N; Sugihara S; Kazukawa I; Minamitani K; Wataki K; Konda S; Inomata H; Sanayama K; Kohno Y
    J Pediatr Endocrinol Metab; 2011; 24(5-6):257-63. PubMed ID: 21823520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
    Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
    Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' disease in children.
    Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
    Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric Graves' disease: outcome and treatment.
    Gruñeiro-Papendieck L; Chiesa A; Finkielstain G; Heinrich JJ
    J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1249-55. PubMed ID: 14714747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.